BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37453366)

  • 21. An explainable supervised machine learning predictor of acute kidney injury after adult deceased donor liver transplantation.
    Zhang Y; Yang D; Liu Z; Chen C; Ge M; Li X; Luo T; Wu Z; Shi C; Wang B; Huang X; Zhang X; Zhou S; Hei Z
    J Transl Med; 2021 Jul; 19(1):321. PubMed ID: 34321016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
    Johnson H; Guo J; Zhang X; Zhang H; Simoulis A; Wu AHB; Xia T; Li F; Tan W; Johnson A; Dizeyi N; Abrahamsson PA; Kenner L; Feng X; Zou C; Xiao K; Persson JL; Chen L
    BMC Med; 2020 Dec; 18(1):376. PubMed ID: 33256740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification and Automated Interpretation of Spinal Posture Data Using a Pathology-Independent Classifier and Explainable Artificial Intelligence (XAI).
    Dindorf C; Konradi J; Wolf C; Taetz B; Bleser G; Huthwelker J; Werthmann F; Bartaguiz E; Kniepert J; Drees P; Betz U; Fröhlich M
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
    Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
    Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
    Mata LA; Retamero JA; Gupta RT; García Figueras R; Luna A
    Radiographics; 2021 Oct; 41(6):1676-1697. PubMed ID: 34597215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative gene expression analysis for the diagnosis of Parkinson's disease using machine learning and explainable AI.
    Bhandari N; Walambe R; Kotecha K; Kaliya M
    Comput Biol Med; 2023 Sep; 163():107140. PubMed ID: 37315380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
    McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P
    Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of prostate cancer diagnosis by machine learning techniques: an algorithm development and validation study.
    Chiu PK; Shen X; Wang G; Ho CL; Leung CH; Ng CF; Choi KS; Teoh JY
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):672-676. PubMed ID: 34267331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images.
    Nir G; Karimi D; Goldenberg SL; Fazli L; Skinnider BF; Tavassoli P; Turbin D; Villamil CF; Wang G; Thompson DJS; Black PC; Salcudean SE
    JAMA Netw Open; 2019 Mar; 2(3):e190442. PubMed ID: 30848813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of statistical machine learning models for rectal protocol compliance in prostate external beam radiation therapy.
    Jones S; Hargrave C; Deegan T; Holt T; Mengersen K
    Med Phys; 2020 Apr; 47(4):1452-1459. PubMed ID: 31981427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.
    Junaid M; Ali S; Eid F; El-Sappagh S; Abuhmed T
    Comput Methods Programs Biomed; 2023 Jun; 234():107495. PubMed ID: 37003039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
    Steuber T; Heidegger I; Kafka M; Roeder MA; Chun F; Preisser F; Palisaar RJ; Hanske J; Budaeus L; Schiess R; Keller T; Semjonow A; Hammerer P; Manka L; Ecke T; Schwentner C; Ohlmann C
    Eur Urol Oncol; 2022 Jun; 5(3):321-327. PubMed ID: 33422560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging the gap between prostate radiology and pathology through machine learning.
    Bhattacharya I; Lim DS; Aung HL; Liu X; Seetharaman A; Kunder CA; Shao W; Soerensen SJC; Fan RE; Ghanouni P; To'o KJ; Brooks JD; Sonn GA; Rusu M
    Med Phys; 2022 Aug; 49(8):5160-5181. PubMed ID: 35633505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
    Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
    J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ExAID: A multimodal explanation framework for computer-aided diagnosis of skin lesions.
    Lucieri A; Bajwa MN; Braun SA; Malik MI; Dengel A; Ahmed S
    Comput Methods Programs Biomed; 2022 Mar; 215():106620. PubMed ID: 35033756
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.